Clinical-stage biotech developing therapeutics targeting CCL24 for fibro-inflammatory diseases like PSC and SSc.
Get notified the moment Chemomab Therapeutics Ltd. (CMMB) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.